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ABSTRACT
Background. In patients with end-stage kidney disease (ESKD), home dialysis offers socio-economic and health benefits
compared with in-centre dialysis but is generally underutilized. We hypothesized that the pre-dialysis course and
institutional factors affect the choice of dialysis modality after dialysis initiation (DI).
Methods. The Peridialysis study is a multinational, multicentre prospective observational study assessing the causes and
timing of DI and consequences of suboptimal DI. Clinical and biochemical data, details of the pre-dialytic course, reasons
for DI and causes of the choice of dialysis modality were registered.
Results. Among 1587 included patients, 516 (32.5%) were judged unsuitable for home dialysis due to contraindications [384
( 24.2%)] or no assessment [106 (6.7%); mainly due to late referral and/or suboptimal DI] or death [26 (1.6%)]. Older age,
comorbidity, late referral, suboptimal DI, acute illness and rapid loss of renal function associated with unsuitability. Of the
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remaining 1071 patients, 700 (65.4%) chose peritoneal dialysis (61.7%) or home haemodialysis (HD; 3.6%), while 371 (34.6%)
chose in-centre HD. Somatic differences between patients choosing home dialysis and in-centre dialysis were minor;
factors linked to the choice of in-centre dialysis were late referral, suboptimal DI, acute illness and absence of a ‘home
dialysis first’ institutional policy.
Conclusions. Given a personal choice with shared decision making, 65.4% of ESKD patients choose home dialysis. Our data
indicate that the incidence of home dialysis potentially could be further increased to reduce the incidence of late referral
and unplanned DI and, in acutely ill patients, by implementing an educational programme after improvement of their
clinical condition.
Keywords: glomerular filtration rate, haemodialysis, peritoneal dialysis, pre-dialysis, uraemia
INTRODUCTION
Home dialysis modalities, peritoneal dialysis (PD) and home
haemodialysis (HD) are generally considered to be beneficial as
compared with in-centre HD. PD does not require blood access
and results in steady, low metabolite levels and is characterized
by lower cost, less time for dialysis, less disturbance of social
life and markedly improved travel opportunities compared with
in-centre HD. Furthermore, mortality was reported to be lower
with PD during the first 2–3 years of dialysis [1, 2], although
other studies do not confirm this finding [3–5]. It was suggested
that differences are due to analytic difficulties and insufficient
correction for differences between PD and in-centre patients [3,
5]. However, the subject is controversial [6].
More frequent dialysis as offered by home HD has been
reported to be associated with improved electrolyte control, re-
duced left ventricular hypertrophy and other signs of heart
disease, better quality of life and reduced mortality [7–10].
The Frequent Hemodialysis Network randomized study showed
a 46% reduction in mortality compared with in-centre HD [11].
Home HD requires more training than PD, is more time-
consuming and offers fewer travel opportunities, and is gener-
ally less utilized. In one study [12], most physicians and health
workers considered home dialysis modalities to be preferable to
facility modalities.
While home dialysis incidence, including that of PD, varies
considerably throughout the world, it remains low in most
countries [13, 14]. There are many possible causes, recently
reviewed by Van et al. [15] and Chan et al. [16]. Economic consid-
erations play a major role in many countries [17] and PD is ac-
tively promoted in some countries as a cheaper modality [18].
Nevertheless, PD prevalence has been falling in many low- and
middle-income countries (LMICs). Possible factors include the
introduction of private–public partnerships for end-stage kid-
ney disease (ESKD) care, where increased HD capacity leads to
an increase in in-centre HD utilization. The absence of well-
designed health economic studies perpetuates the myth of
lower cost of in-centre HD in LMICs.
Despite medical and socio-economic advantages, PD and
home HD remain underutilized dialysis modalities worldwide.
As non-medical barriers are thought to play an important role
[19, 20], many countries have introduced programmes to in-
crease the use of home dialysis by general stimulatory meas-
ures [17]. Recently, the USA introduced the Advancing
American Kidney Health programme, aimed at reaching the tar-
get of having 80% of incident patients with ESKD begin care
with a pre-emptive kidney transplant or home dialysis by 2025
[21]. The successful implementation of such programmes will
require an improved understanding of factors influencing pa-
tient pathways during the course of pre-dialysis care, especially
within renal care management models that are built on a
patient-centric approach with shared decision-making
involving patients, nurses, physicians and other caregivers.
The effects of pre-dialysis care and early dialysis education
on subsequent outcomes of dialysis treatment have been stud-
ied extensively. In addition to important effects such as a lower
incidence of suboptimal dialysis initiation (DI) and reduced
morbidity and mortality, the presence of programmes for pre-
dialysis care and early dialysis education is generally associated
with a higher incidence of home modalities, particularly PD
[22–26]. A meta-analysis of studies in this area concluded that
a pre-dialysis education programme was associated with a
doubling of PD incidence [27].
The Peridialysis study is a prospective, multicentre, interna-
tional observation study of the relevance of pre-dialysis renal
care on the causes and timing of DI, modality choice and clinical
outcomes [28, 29]. This study focuses on modality choice and its
aim was to explore factors during the pre-dialysis course, in-
cluding patient-related factors and organizational institutional
factors, some of which could be potentially modifiable, that af-
fect the choice of dialysis modality before and after DI.
MATERIALS AND METHODS
This observational multinational multicentre prospective study
comprised 1588 ESKD patients who started dialysis over a 3-
year period at 15 nephrology departments from seven Nordic
and Baltic countries. The methodology of the Peridialysis proj-
ect has been previously described [28, 29]. All centres delivered
both PD and HD. They were publicly financed, with no dialysis
costs to the patient, but with varying financial support for medi-
cine costs. One centre reported suboptimal availability of HD
stations, but otherwise there were no restrictions of access to
dialysis care. They all had a developed and working multidisci-
plinary pre-dialysis care structure, including specialist physi-
cian and nursing treatment. Thirteen of 15 centres also had a
dietician and 5 of 15 had a clinical social worker.
The most common method of assessing residual renal func-
tion and guiding clinical treatment was estimated glomerular
filtration rate (eGFR) as measured by the Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI) formula [30].
Patients
Patients included in this study were consecutive patients start-
ing chronic dialysis therapy for ESKD at the participating
centres between 1 January 2015 and 31 December 2017. Five
centres had a shorter recruiting period.
A patient was considered to have ESKD at first dialysis if the
patient was diagnosed as having ESKD according to the treating
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physician (in practice, this was the most commonly used defini-
tion), the patient received dialysis treatment for >90 days and if
the doctor was in doubt whether the patient had acute or
chronic renal failure, the patient was included retrospectively
as soon as there was no doubt that the patient had chronic renal
failure and ESKD .
The study protocol was approved by the ethical review
boards in centres located in countries where according to the
country’s regulations such approval was required. The study
was approved by the Swedish Ethical Review Authority ( 2017/
7). However, in Denmark, due to the observational, non-
interventional design of the study using anonymized patient
data, the study protocol was not considered to be eligible for
ethical review. Informed consent, either written or verbal
depending on the regulations in the different countries, was
obtained from participants in all centres, including those in
Denmark, with the exception of Lithuania, where patient
permission was waived by the ethics board (P2-BE-2-9/2014).
The study is registered with ClinicalTrials.gov (NCT02488200).
Outcome: modality choice
Modality choice was decided before DI or shortly thereafter.
Modality choice was categorized as either patient modality
choice (between PD, home HD or in-centre HD), usually in the
context of a shared decision-making process with the doctors
and nurses; unsuitability for patient choice or no information
given about home dialysis modalities. Unsuitability was further
classified as HD not possible, physical contraindication to PD,
mental contraindication to PD and abdominal contraindication
to PD. Changes in modality during the first year after DI were
registered. No information given was assessed by a retrospec-
tive review of patient notes.
Patient clinical data
The following patient data were registered at DI: age, sex,
height, weight, body mass index (BMI) and renal diagnosis. The
presence of the following comorbidities was registered: previ-
ous myocardial infarction, heart failure, cardiac atherosclerosis,
cerebrovascular disease, diabetes, peripheral atherosclerosis,
previous cancer (except basocellular), chronic pulmonary dis-
ease, chronic liver disease, psychiatric disease, previous renal
transplantation and other chronic conditions.
Dialysis access at first dialysis was registered. DI was classi-
fied as optimal if the access was an arteriovenous fistula (AVF)
or graft (AVG); the access was a tunnelled catheter as the
patient’s permanent access due to inability to place an AVF/
AVG or the access was a PD catheter and PD was started >6 days
after placement.
DI was suboptimal if the access was a temporary vascular
catheter; the access was a tunnelled catheter, but a later AVF/
AVG was planned or the access was a PD catheter and PD was
started <6 days after placement.
The period between PD catheter placement and the start of
PD should preferably be 2–3 weeks in order to avoid leaks and
hernias. Early peritoneal DI was therefore judged suboptimal.
The choice of <6 days was derived from the Danish Society of
Nephrology treatment quality indicators. Late referral was de-
fined as referral to the specialist nephrology unit <3 months be-
fore DI. As many pre-emptive transplants were often assessed
and treated at other departments, they were excluded from the
study.
Clinical data for this population have previously been pub-
lished [28]. For the purposes of this study, clinical symptoms
were classified as present or not present and as primary cause
of DI or not primary cause of DI. Life-threatening conditions
were defined as the presence of pulmonary stasis, dyspnoea,
cardiac symptoms, pericarditis, acidosis or hyperkalaemia (as
assessed by the treating physician) and similarly classified.
Patient biochemical data
The following biochemical data prior to or in conjunction with
the first dialysis were registered: blood haemoglobin, plasma
concentrations of urea, creatinine, potassium, hydrogen car-
bonate (bicarbonate), albumin, C-reactive protein (CRP), total or
ionized calcium and phosphate. Most centres measured ionized
calcium, for other centres, ionized calcium was assumed to be
50% of total calcium.
Whenever available, plasma creatinine concentration and
date of measurement were registered at the following time
points: referral to the nephrology department, 6 and 3 months
before DI and at the time of information about dialysis, dialysis
access prescription, dialysis access placement and first dialysis.
The time of information was defined as initiation of personal-
ized dialysis information with the purpose of choosing a dialy-
sis modality. If data on creatinine were not available on the
same date, the value closest in time to this date was chosen.
eGFR was calculated using the CKD-EPI formula [30]. Patients
had often received general information about dialysis at a very
early point; information about dialysis is here defined as the ini-
tiation of detailed information in order to make a final choice of
modality and plan for surgical placement of access and would
be expected to be completed within 1 month.
Physician DI motivation questionnaire
Physicians gave details in an English-language questionnaire of
their reasons for prescribing chronic dialysis at DI. They could
choose between several pre-stated clinical and/or biochemical
reasons. Details of these have already been published [28]. For
the purposes of this study, reasons were defined as primarily
clinical or primarily biochemical.
Physician data
Participating physicians were requested to provide the follow-
ing anonymized personal data: age, sex, specialist qualification,
duration of physician experience and duration of specialist
nephrology experience.
Centre data
Centres supplied estimates of incidence rates of HD and PD. The
number of nephrology specialists at the centre was noted.
Centre policies concerning anaemia treatment, dialysis plan-
ning, access placement and DI were registered. The existence of
a ‘home dialysis first’ policy was noted. This was defined as a
belief by the clinic that, for one or more reasons, home dialysis
is the preferred modality in the absence of contraindications
and that this belief was communicated to the patient.
Statistics
Data are presented as mean 6 standard deviation for normally
distributed variables, median (interquartile range) for non-
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normally distributed variables or frequencies and percentages
for categorical variables. All variables used in the analyses were
categorical and were compared using chi-squared tests. Odds
ratios (ORs) were calculated according to Altman [31]. A signifi-
cance level of <0.05 was considered significant. All variables
that were significant on univariate analyses were included in a
forward stepwise regression analysis in order to identify inde-
pendent associations with modality choice. Significance values
were expressed as P< 0.05, P< 0.01, P< 0.001.
RESULTS
A total of 1587 patients were included in the study. This was
19% below the expected total incidence, suggesting that some
patients were not included. The number of non-included
patients was not registered, nor was the cause of their non-
inclusion. Seventeen (1%) patients were not included due to a
pre-emptive transplantation. This was known to be an underes-
timate of the true incidence of pre-emptive transplantation,
since these patients were often assessed at other clinics. The
median number of included patients per centre was 67 (range
16–198). No data concerning non-included patients were regis-
tered. The mean age of the 1587 patients was 63.8 6 15.3 years
and 35.9% were female. Their renal diagnoses were glomerulo-
nephritis [283 (17.8%)], chronic interstitial nephropathy [185
(11.7%)], polycystic renal disease [106 (6.7%)], diabetic nephropa-
thy [388 (24.4%)], hypertensive nephropathy [303 (19.1%)] and
other [179 (11.3%)] or unknown [143 (9.0%)] aetiology. The vast
majority were Caucasian.
Treatment modality and causes of choice
The distribution of stated causes of modality choice is shown in
Figure 1. Of 1587 included patients, 516 (32.5%) patients were
judged not suitable for a personal choice. Of these, PD was con-
traindicated in 338 (21.3%) patients for physical [142 (8.9%)],
mental [80 (5.0%)] or abdominal [116 (7.3%)] reasons. HD was
contraindicated in 46 (2.9%) patients. A total of 106 (6.7%)
patients were not informed about home dialysis modalities and
deaths before modality choice occurred in 26 (1.6%).
Among the remaining 1071 patients (representing 67.5% of
the 1587 patients) with a personal choice of modality, 700
(65.4%) chose home dialysis, either PD [661 (61.7%)] or home HD
[39 (3.6%)], while 371 patients chose in-centre HD. The overall
incidence of PD in the 15 centres varied between 19% and 57%,
with one outlier (4%).
Among the 661 patients who chose PD, some had to start di-
alysis in a suboptimal way. Fifty-eight (8.8%) of these started on
suboptimal PD and 128 (19.4%) started on suboptimal HD. Of the
latter, 81 (63%) switched subsequently to PD, while 40 (31%)
remained on HD, 3 (2%) changed to home HD and 4 (3%)
regained renal function. There were some differences between
the centres in the ability to fulfil these patients’ wishes for PD.
In seven centres, all patients who started on dialysis using sub-
optimal HD subsequently switched to PD, while in three centres
the figure was <70%. A further 18 patients (1% of total) switched
to PD despite PD not being their original choice. Initially, six of
these had chosen HD, six had not been informed about PD and
six were previously thought to be unsuited to PD. In all, 632
(39.8% of total) patients were treated with PD and 39 (2.5% of to-
tal) patients initially chose home HD. None of these received
home HD as the initial modality. Only 19 (49%) later received
home HD, while 5 (13%) received a renal transplant, 14 (36%)
remained on in-centre HD and 1 regained renal function.
However, a further 23 patients (1.4% of all patients) were also
later treated with home HD, their initial modality choice being
PD [8 patients (35%)], in-centre HD [1 (4%)], PD not possible [13
(57%)] or home dialysis not offered [1 (4%)]. In all, 42 (2.6% of to-
tal) were treated with home HD.
Factors associated with unsuitability for patient
modality choice
Significant univariate and multivariable associations to unsuit-
ability for modality choice are shown in Table 1 and Figure 2.
Unsurprisingly, advanced age and most comorbid diseases were
associated with increased unsuitability. Hepatic and cardiac
disease, cardiac failure in particular, were major factors in
unsuitability for HD. Sixteen (26.2%) patients with psychiatric
disease had mental contraindications to PD. Cancer and obesity
were associated with abdominal contraindication to PD. PD was
considered contraindicated in 12 of 24 (50%) patients with a
BMI>40 kg/m2. High levels of urea and CRP and low plasma al-
bumin were associated to unsuitability, while eGFR showed no
relationship.
Many factors during the pre-dialytic course were associated
with unsuitability. Dialysis information given in conjunction
with a low eGFR, rapid uraemia progression, late referral, subop-
timal DI and life-threatening DI cause were all associated
with increased unsuitability. Rapid uraemia progression and
late referral were significant factors even after correction for
comorbidity.
Organizational and physician-related factors were minor
factors and were not significant on a multivariable analysis.
Factors associated with not receiving modality choice
information
Significant univariate and multivariable associations to not re-


















FIGURE 1: Distribution of stated causes of modality choice.
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Table 1. Clinical, biochemical and organizational factors linked to unsuitability for patient modality choice
Unsuitable for patient modality choice
Factor
Patient





No. of patients 1455 1071 (73.6) 80 (5.5) 116 (8.0) 142 (9.8) 46 (3.2) 384 (26.4)
Patient age (years) <60 400 (79.3) 25 (5.0) 31 (6.2) 35 (7.0) 13 (2.6) 104 (20.7)
60 671 (70.5) 55 (5.8) 85 (9.0)a 107 (11.3)b 33 (3.5) 280 (29.5)c 1.60 (1.24–2.07)c
BMI (kg/m2) <30 733 (75.1) 53 (5.4) 69 (7.1) 89 (9.1) 32 (3.3) 243 (24.9)
29 196 (68.3) 13 (4.5) 34 (11.9)b 31 (10.8) 13 (4.5) 91 (31.7)a 1.40 (1.05–1.87)a
Comorbidity
Any comorbidity No 331 (84.0) 14 (3.6) 19 (4.8) 24 (6.1) 6 (1.5) 63 (16.0)
Yes 740 (69.8) 66 (6.2)a 97 (9.1)b 118 (11.1)c 40 (3.8)c 321 (30.2)c 2.27 (1.69–3.08)c
Myocardial
infarction
No 960 (74.2) 72 (5.6) 107 (8.3) 116 (9.0) 39 (3.0) 334 (25.8)
Yes 111 (68.9) 8 (5.0) 9 (5.6) 26 (16.1)b 7 (4.4) 50 (31.1)a 1.29 (0.91–1.85)a
Cardiac failure No 913 (75.1) 67 (5.5) 101 (8.3) 109 (9.0) 25 (2.1) 302 (24.9)
Yes 158 (65.8) 13 (5.4) 15 (6.3) 33 (13.8) 21 (8.8)c 82 (34.2)b 1.57 (1.17–2.11)b
All cardiac No 731 (76.2) 46 (4.8) 84 (8.8) 78 (8.1) 20 (2.1) 228 (23.8)
Yes 340 (68.5) 34 (6.9)a 32 (6.6) 64 (12.9)b 26 (5.2)c 156 (31.5)b 1.47 (1.116–1.87)b
Cerebrovascular No 961 (75.3) 70 (5.5) 103 (8.1) 106 (8.3) 37 (2.9) 316 (24.7)
Yes 110 (61.8) 10 (5.6) 13 (7.3) 36 (20.2)c 9 (5.1)a 68 (38.2)c 1.88 (1.35–2.61)c,C
DM No 703 (74.8) 52 (5.5) 76 (8.1) 88 (9.4) 21 (2.2) 237 (25.2)
Yes 368 (71.5) 28 (5.4) 40 (7.8) 54 (10.5) 25 (4.9)b 147 (28.5) 1.18 (0.93–1.51)
Peripheral
vascular
No 955 (74.6) 72 (5.6) 97 (7.6) 120 (9.4) 36 (2.8) 325 (25.4)
Yes 116 (66.3) 8 (4.6) 19 (10.9) 22 (12.6) 10 (5.7)a 59 (33.7)a 1.49 (1.07–2.10)a
Cancer No 923 (75.4) 67 (5.5) 78 (6.4) 115 (9.4) 41 (3.3) 301 (24.6)
Yes 148 (64.1) 13 (5.6) 38 (16.5)c 27 (11.7) 5 (2.2) 83 (35.9)c 1.72 (1.28–2.32)c,A
Pulmonary No 985 (74.7) 71 (5.4) 101 (7.7) 123 (9.3) 39 (3.0) 334 (25.3)
Yes 86 (63.2) 9 (6.6) 15 (11.0) 19 (14.0)a 7 (5.1) 50 (36.8)b 1.71 (1.18–2.48)b,A
Hepatic No 1037 (74.0) 78 (5.6) 112 (8.0) 137 (9.8) 38 (2.7) 365 (26.0)
Yes 34 (64.2) 2 (3.8) 4 (7.5) 5 (9.4) 8 (15.1)c 19 (35.8) 1.59 (0.89–2.82)
Previous
transplant
No 1019 (73.9) 76 (5.5) 107 (7.8) 135 (9.8) 42 (3.0) 360 (26.1)
Yes 52 (68.4) 4 (5.3) 9 (11.8) 7 (9.2) 4 (5.3) 24 (31.6) 1.31 (0.79–2.15)
Psychiatric No 1036 (74.3) 64 (4.6) 114 (8.2) 134 (9.6) 46 (3.3) 358 (25.7)
Yes 35 (57.4) 16 (26.2)c 2 (3.3) 8 (13.1) 0 (0) 26 (42.6)b 2.15 (1.28–3.62)b,B
Comorbidity
number
0 481 (78.6) 32 (5.2) 44 (7.2) 45 (7.4) 10 (1.6) 131 (21.4) 1.00 (Referent)
Subgroups 1 324 (73.1) 24 (5.4) 42 (9.5) 43 (9.7) 10 (2.3) 119 (26.9)a 1.35 (1.01–1.79)a





No 843 (75.9) 57 (5.1) 81 (7.3) 99 (8.9) 31 (2.8) 268 (24.1)
Yes 153 (62.7) 19 (7.8) 25 (10.2)a 35 (14.3)b 12 (4.9)a 91 (37.3)c 1.87 (1.39–2.51)c,A
Suboptimal DI No 724 (80.2) 35 (3.9) 62 (6.9) 61 (6.8) 21 (2.3) 179 (19.8)
Yes 346 (62.8) 45 (8.2)c 54 (9.8)b 81 (14.7)c 25 (4.5)b 205 (37.2)c 2.40 (1.89–3.04)c
eGFR decrease 3–


















<6 125 (67.6) 13 (7.0) 15 (8.1) 24 (13.0) 8 (4.3) 60 (32.4) 1.00 (Referent)
6–12 535 (74.8) 39 (5.5) 52 (7.3) 70 (9.8) 19 (2.7) 180 (25.2)a 0.70 (0.49–1.00)a





















Urea (mM) <20 103 (76.9) 6 (4.5) 13 (9.7) 10 (7.5) 2 (1.5) 31 (23.1) 1.00 (Referent)
20–29.9 379 (77.8) 24 (4.9) 38 (7.8) 29 (6.0) 17 (3.5) 108 (22.2) 0.95 (0.60–1.49)
30 552 (70.1) 50 (6.4) 61 (7.8) 97 (12.3)c 27 (3.4) 235 (29.9) 1.41 (0.92–2.17)
Albumin (g/L) <30 281 (65.0) 34 (7.9)a 45 (10.4)b 51 (11.8)b 21 (4.9)b 151 (35.0)c 2.15 (1.60–2.90)c,B
30–34.9 282 (74.4) 16 (4.2) 31 (8.2) 42 (11.1)a 8 (2.1) 97 (25.6)a 1.38 (1.00–1.90)a
35 393 (80.0) 27 (5.5) 28 (5.7) 36 (7.3) 7 (1.4) 98 (20.0) 1.00 (Referent)
CRP (mg/L) <50 809 (77.3) 52 (5.0) 80 (7.6) 74 (7.1) 32 (3.1) 238 (22.7)
(continued)
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Figure 2. The main factors were late referral and suboptimal DI.
Patients with late referral were 5.75 [95% confidence interval
(CI) 3.77–8.79] times more likely not to receive information,
while those receiving suboptimal DI were 9.63 (95% CI 5.52–16.8)
times more likely not to receive information. Patients not re-
ceiving information were characterized by a low eGFR and low
plasma albumin at DI and elevated CRP. University departments
and departments without a ‘home dialysis first’ policy were less
likely to give modality choice information.
Factors associated with patient modality choice
Significant univariate and multivariable associations to
modality choice for patients offered a personal choice are
shown in Table 3 and Figure 2. For statistical purposes, in-
centre HD and home HD were compared individually with
PD and home dialysis (home HD and PD combined) with in-
centre HD.
The subgroup of patients choosing home HD was relatively
small, permitting only limited analysis. Patients with younger
age [<60 years; OR 2.56 (95% CI 1.30–5.01), P< 0.01], female sex
[OR 2.17 (95% CI 1.12–4.23), P< 0.05], polycystic disease [OR 8.79
(95% CI 3.59–21.5), P< 0.001], a higher eGFR at DI [7 mM; OR
3.23 (95% CI 1.59–6.58), P< 0.01] and a low plasma urea at DI
[<20 mM; OR 2.70 (95% CI 1.03–7.09), P< 0.05] were more likely to
choose home HD than in-centre HD.
Patients choosing in-centre HD had a similar age and sex as
those choosing PD and did not differ significantly in terms of
comorbidity. Obese patients were less likely to choose PD and
patients with polycystic renal disease more likely to choose PD.
Important factors for the choice of in-centre HD were late infor-
mation concerning dialysis modalities, late referral, suboptimal
Table 1. (continued)
Unsuitable for patient modality choice
Factor
Patient





50 153 (56.9) 22 (8.2)b 27 (10.0)a 56 (20.8)c 11 (4.1) 116 (43.1)c 2.58 (1.95–3.41)c,C
Life-threatening
cause
Not primary 889 (77.1) 58 (5.0) 81 (7.0) 96 (8.3) 29 (2.5) 264 (22.9)
Primary 156 (59.1) 19 (7.2) 31 (11.7)c 41 (15.5)c 17 (6.4)c 108 (40.9)c 2.33 (1.76–3.09)c
Hospital
University hospital No 205 (79.5) 11 (4.3) 19 (7.4) 22 (8.5) 1 (0.4) 53 (20.5)
Yes 866 (72.3) 69 (5.8) 97 (8.1) 120 (10.0) 45 (3.8)b 331 (27.7) 1.48 (1.07–2.05)a
Home dialysis first
policy
No 208 (73.2) 14 (4.9) 21 (8.1) 38 (13.4) 3 (1.1) 76 (26.8)
Yes 863 (73.7) 66 (5.6) 95 (8.1) 104 (8.9)a 43 (3.7)a 308 (26.4) 0.98 (0.73–1.31)
Physician age <50 332 (77.2) 21 (4.9) 25 (5.8) 34 (7.9) 18 (4.2) 98 (22.8)
50 304 (71.4) 27 (6.3) 36 (8.5) 46 (10.8) 13 (3.1) 122 (28.6) 1.36 (0.99–1.85)0.05
Physician sex Male 329 (76.3) 23 (5.3) 32 (7.4) 39 (9.0) 8 (1.9) 102 (23.7)
Female 307 (72.2) 25 (5.9) 29 (6.8) 41 (9.6) 23 (5.4)b 118 (27.8) 1.24 (0.91–1.69)
Significant factors only. OR shown for no choice (combined) versus patient choice. Row percentages in brackets. Bold type: independent significant factors on multivar-
iable analysis; 132 patients were excluded (106 were not assessed and 26 patients died).
Univariate analysis: aP<0.05, bP<0.01, cP<0.001. Multivariable analysis: AP<0.05, BP<0.01, CP<0.001. Only variables significant in the univariate analysis were in-
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FIGURE 2: Relationship of pre-dialysis factors to choice of modality. The percentage figures refer to the percentage of patients in each modality choice group with the
relevant factor.
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DI and severe symptomatic and biochemical uraemia at DI.
Patients treated by physicians with lengthy nephrology experi-
ence (>9 years) were less likely to choose PD. There was an
insignificant tendency for physicians with greater experience to
prescribe home HD (<10 years, 1.9%; 10–19 years, 3.9%;
>19 years, 5.3%; P¼ 0.07). Physician age, physician sex, specialist
qualification and number of specialists per patient had no effect
on modality choice.
Although 11 of the 15 centres were able to provide
subacute PD, PD was relatively uncommon as the initial mo-
dality for patients with suboptimal DI. Seventy-two patients
(4.5% of all 1588 patients, 10.9% of PD starts) received sub-
acute PD, with the incidence varying between 1% and 33% for
different centres. More frequent use of subacute PD seemed
to be associated with a higher incidence of PD choice: in four
centres that did not provide subacute PD, PD incidence was
31.2%; in centres with little use of subacute PD (2–9%, 7
centres), it was 40.7%; and in centres with high use of sub-
acute PD (13–27%, 4 centres), it was 51.6%.
Ten of 15 centres provided assisted PD, defined as
professional help in the home. This was not associated with the
incidence of PD choice (PD incidence in centres with and with-
out assisted PD was 40.0 and 40.5%, respectively).
DISCUSSION
This study, comprising 1587 ESKD patients starting dialysis in
centres in the Nordic and Baltic countries, shows that among
patients who had a personal choice of dialysis modality, 65.3%
chose home dialysis using PD (61.7%) or in some cases home HD
(3.6%). Whereas most ESKD patients given a personal choice
chose home dialysis, many patients did not receive timely
Table 2. Clinical, biochemical and organizational factors associated with lack of information concerning home dialysis modalities
Factor Number (%) OR (95% CI)
Patients 106 (6.7)
Diabetic nephropathy No 90 (7.7)
Yes 16 (4.1) 0.53 (0.31–0.91)a
Comorbidity
DM No 78 (7.7)
Yes 28 (5.2) 0.66 (0.42–1.03)0.06
Cancer No 80 (6.1)
Yes 26 (10.1) 1.70 (1.07–2.70)a
Comorbidity number 0 54 (8.0) 1.00 (Referent)
Subgroups 1 23 (4.9) 0.59 (0.36–0.98)a
>1 29 (6.6) 0.82 (0.51–1.31)
Pre-dialysis course
Late referral (<3 months) No 42 (3.6)
Yes 55 (18.4) 5.75 (3.77–8.79)c,C
Suboptimal DI No 15 (1.6)
Yes 91 (14.2) 9.63 (5.52–16.8)c,C








eGFR (mL/min/1.73 m2) 7 32 (4.5)
<7 73 (8.8) 2.04 (1.33–3.14)c
Albumin (g/L) <30 45 (9.4) 2.37 (1.39–4.05)b
30–34.9 24 (6.0) 1.47 (0.80–2.68)
35 21 (4.1)b 1.00 (Referent)
CRP (mg/L) <50 67 (6.0)
50 36 (11.8) 2.04 (1.33–3.13)c
Initial dialysis
Dialysis cause Clinical 44 (4.7)
Biochemical 59 (10.2)c 2.31 (1.54–3.47)c
Life-threatening cause Not primary 75 (6.1)
Primary 29 (9.9)a 1.66 (1.06–2.58)a
Hospital
University hospital No 5 (1.9)
Yes 101 (7.8)c 4.32 (1.74–10.7)b,B
Home dialysis first policy No 45 (13.4)
Yes 61 (4.9) 0.33 (0.22.0.50)c,C
Physician age <50 43 (9.0)
50 22 (4.8) 0.51 (0.30–0.87)a
Nephrologist vintage <10 18 (4.5)
10 47 (8.8) 2.03 (1.16–3.55)a
Univariate analysis: aP<0.05, bP<0.01, cP<0.001. Multivariable analysis: AP<0.05, BP<0.01, CP<0.001. Only variables significant in the univariate analysis were in-
cluded in the multivariable analysis. Comparison to all other patients. Significant factors only. Bold type: independent significant factors on multivariable analysis.
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information about dialysis modality options due to potentially
modifiable factors such as late referral and suboptimal DI.
Based on our data, it seems likely that the incidence of DI using
home dialysis (44.1% of all 1587 patients) could potentially have
been further increased by efforts to reduce the incidence of late
referral and unplanned DI. Moreover, our data may imply that
acutely ill patients starting suboptimal DI, in most cases using
subacute HD, could probably benefit from an educational pro-
gramme (possibly repeated) after their clinical condition has
improved and this could potentially increase the incidence of DI
using home dialysis.
The centres involved in this study were similar in many
respects. The incidence of DI using home dialysis was, from an in-
ternational perspective, relatively high in most of the participating
centres. The choice of modality was independent of economic con-
siderations since all modalities were available and free of charge to
patients. All centres offered a pre-dialysis education programme to
patients with timely referral, although the quality of these
Table 3. Clinical, biochemical and organizational factors affecting choice of dialysis modality in 1072 patients offered a personal choice of
modality
Variable Value In-centre HD, n (%) PD, n (%) Home HD, n (%)
OR for home dialysis
versus in-centre HD (95% CI)
Patients 1071 371 (34.6) 661 (61.7) 39 (3.6)
Patient age (years) <60 133 (33.3) 244 (60.9) 23 (5.8)
60 238 (35.5) 417 (62.1) 16 (2.4)b 0.92 (0.71–1.20)
Sex Male 250 (36.1) 423 (61.1) 19 (2.8)
Female 121 (31.9) 238 (62.8) 20 (5.3)0.06 1.21 (0.92–1.57)
BMI (kg/m2) <30 253 (34.5) 459 (62.6) 21 (2.9)
30 85 (43.4)b 98 (50.0) 13 (6.6) 0.69 (0.50–0.95)a,B
Polycystic disease No 357 (35.8) 611 (61.3) 29 (2.9)
Yes 14 (18.9)a 50 (67.6) 10 (13.5)c 2.39 (1.32–4.34)b,A
Comorbidity
Any comorbidity No 101 (30.5) 213 (64.4) 17 (5.1)
Yes 270 (36.5) 448 (60.5) 22 (3.0) 0.76 (0.58–1.01)0.06
Previous transplant No 349 (34.3) 636 (62.4) 34 (3.3)
Yes 22 (42.3) 25 (48.1) 5 (9.6)b 0.71 (0.40–1.25)
Pre-dialysis course
Late referral (<3 months) No 274 (32.4) 537 (63.6) 34 (4.0)
Yes 71 (46.4)b 78 (51.0) 4 (2.6) 0.55 (0.39–0.79)c,B
Suboptimal DI No 214 (29.6) 485 (67.0) 25 (3.5)
Yes 157 (45.4)c 175 (50.6) 14 (4.1) 0.51 (0.39–0.66)c,C























12 88 (26.8)c 226 (68.9) 14 (4.3) 2.36 (1.54–3.62)c
Late dialysis information











eGFR (mL/min/1.73 m2) 7 151 (30.0) 326 (64.7) 27 (5.4)
<7 217 (39.2)b 324 (58.6) 12 (2.2)a 1.51 (1.17–1.95)b
Urea (mM) <20 23 (22.3) 74 (71.8) 6 (5.8)
20–29.9 104 (27.4) 255 (67.3) 20 (5.3) 0.76 (0.45–1.27)
30 237 (42.9)c 302 (54.7) 13 (2.4) 0.38 (0.23–0.63)c,C
CRP (mg/L) <50 266 (32.9) 512 (63.3) 31 (3.8)
50 64 (41.8)a 83 (54.3) 6 (3.9) 0.68 (0.48–0.97)a
Initial dialysis cause
Symptoms None 44 (25.9) 119 (70.0) 7 (4.1)
Some 318 (36.5)b 524 (60.1) 30 (3.4) 0.61 (0.42–0.88)b,C
Life-threatening cause Not primary 288 (32.4) 567 (63.8) 34 (3.8)
Primary 74 (47.4)c 79 (50.6) 3 (1.9) 0.53 (0.38–0.75)c
Hospital
Home dialysis first policy No 52 (60.5) 31 (36.0) 3 (3.5)
Yes 319 (32.4 )c 630 (64.0) 36 (3.7) 3.19 (2.03–5.02)c
Physician
Nephrologist vintage, years <10 79 (28.6) 185 (67.0) 12 (4.3)
10 143 (39.7)b 202 (56.1) 15 (4.2) 0.61 (0.44–0.85)b,A
Significant factors only. In-centre HD and home HD each compared with PD. Bold type: independent significant factors on multivariable analysis. OR shown for home
dialysis (combined home HD and PD) versus in-centre HD. In-centre HD and home HD compared with PD. Univariate analysis: aP<0.05, bP<0.01, cP<0.001.
Multivariable analysis: AP< 0.05, BP< 0.01, CP< 0.001. Only variables significant in the univariate analysis were included in the multivariable analysis.
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programmes was not assessed in this study. Most departments had
a ‘home dialysis first’ policy. These factors may explain the gener-
ally high incidence of home dialysis in this population.
Reasons for (perceived) contraindications to home dialysis were
classified as physical (medical conditions preventing practical per-
formance of home dialysis), mental (e.g. psychiatric disease and de-
mentia) and PD and abdominal problems. Contraindications to PD
were noted in 21.2% of all 1588 patients and contraindications to HD
in 3% of the patients. These findings are similar to previously
reported data from Europe and the USA [26, 32, 33].
Unsurprisingly, obesity, older age, hypoalbuminaemia and
comorbidity were associated with the stated presence of contra-
indications. Additional risk factors included late referral, subop-
timal DI, particularly due to life-threatening conditions, rapid
uraemia progression and a high CRP (Figure 2). This is perhaps
surprising, since these contraindications are in principle tempo-
rary problems. These observations suggest that delaying deci-
sions on modality choice until the patient is healthy, or
repeating dialysis information after 2–3 months, might increase
the incidence of home HD. A recent study [34] demonstrated
that an education programme initiated after unplanned DI can
increase the incidence of home dialysis.
A minority of patients (7%) were not assessed for home dial-
ysis. The clinical differences between these patients and other
patients were minor, the main risk factors being late referral
and suboptimal DI (Figure 2). This suggests again that the estab-
lishment of a formalized evaluation and education programme
for these patients after DI should be an integrated element in
departmental practice.
Most patients (67.5%) were offered a personal, informed choice
of dialysis modality, regardless of the existence of a ‘home dialysis
first’ policy. The term ‘personal’ should not be interpreted literally;
most patients will have participated in a shared decision-making
process, with input from doctors and nurses. For instance, obese
patients were apparently often advised to choose HD. Among
patients with a personal choice, 61.7% chose PD, a somewhat higher
figure than described in the literature [35]. This seemed to be related
to the high prevalence of ‘home dialysis first’ policies at the partici-
pating centres. Another factor may be that all the centres in this
study provided home dialysis. The results may not have been the
same if centres had been obliged to transfer patients to other
centres to perform dialysis at home, as is the case in certain other
countries. Other well-known non-medical factors affecting patient
choice (level of education, revenue, housing, familial status, etc.)
were not assessed in this study.
All centres offered home HD, but most patients chose PD.
This finding is similar to international results. However, the low
incidence of home HD may have been related to physician bias,
in that some centres, e.g. in New Zealand, exhibit almost similar
uptake for both techniques. Further data concerning this ques-
tion were not available.
Clinical differences between the three modality groups for
patients given a personal choice were minor, although patients
choosing in-centre HD had a marginally higher morbidity. This
contrasts with the Netherlands Cooperative Study on the
Adequacy of Dialysis [36], where older patients were more likely
to choose HD, and with the Offering Patients Therapy Options in
Unplanned Start study [37], where patients with a high comor-
bidity index were more likely to choose PD. Patients with poly-
cystic kidney disease were significantly more likely to choose
home dialysis, particularly home HD, independent of other clini-
cal factors. Again, circumstances occurring during the pre-
dialysis course, up to DI, seemed to affect patient choice.
Patients with late referral, rapid loss of renal function,
suboptimal DI, life-threatening disease or symptomatic uraemia;
those having a high urea and CRP concentration; and those with
low plasma albumin at DI were more likely to choose in-centre
HD. This is in accordance with the literature [38–42]. One possi-
ble explanation is that, at the time of modality choice, these
patients had not fully recovered from their poor clinical condi-
tion at DI and felt unable to cope with the responsibility for
home dialysis.
These findings may have particular implications for coun-
tries where PD is used very little. It is important to stress that
based on a patient-centric approach with shared decision-mak-
ing, each patient should have the right to be informed about
home dialysis options.
Previous renal transplantation increased home HD choice,
as found previously [43]. The cause of this is unknown. One pos-
sibility is that these patients have a long ESKD history and may
be better informed about the benefits of home dialysis. Some
may no longer be suitable for transplantation and home HD
may represent their best chance of long-term survival.
The influence of diabetes on modality choice is controver-
sial, with one study showing an increased uptake of PD [34] and
another reduced [36]. We found little effect of diabetes on mo-
dality choice. The influence may be conflicting: while diabetics
may have a reduced possibility of home dialysis due to high
morbidity, they are usually referred early to clinics, with the
consequent possibility of optimal planning.
As previously noted [37], not all patients opting for home di-
alysis after suboptimal DI actually received this therapy. This
may have been due to the patient changing his/her mind or a
reassessment of patient suitability, but the considerable differ-
ences between centres suggest that suboptimal institutional
planning after DI is a factor in some centres.
Institutional factors seemed to play a role in modality
choice. University hospitals were more likely to judge patients
unsuitable for home dialysis and less likely to assess patients
for home dialysis. This could be related, at least in part, to a dif-
ference in patient characteristics since these hospitals are more
likely to treat sicker patients. One might hypothesize that the
larger number of trainees at these departments could have con-
tributed to this difference. More importantly, the presence of a
‘home dialysis first’ policy at a department was a highly signifi-
cant factor for predicting both timely assessment and informa-
tion concerning home dialysis, and subsequent patient choice
of home dialysis. The departments seemed to be following
shared decision-making principles, such that the physicians’
opinions affected patient choice. However, the patient:nephrol-
ogist ratio was not a factor, in accordance with previous find-
ings for Europe [44]. Patients treated by physicians with lengthy
specialist experience were—perhaps surprisingly—less likely to
be informed of and less likely to choose home dialysis. The
causes of this relationship are unclear.
The use of PD for suboptimal DI has been practised in some
centres for many years [45, 46]. It is more economical [47] and
may increase the incidence of PD. Most centres in this study pro-
vided urgent-start PD, but only three centres commonly used it.
These centres had a higher PD incidence (52% of all DI). Whether
urgent-start PD per se increases PD incidence or is just a marker
of institutional dedication to home dialysis is debatable.
Being an observational study, any causal explanations of
these findings must be purely speculative. Some relations are
obviously causative, e.g. high morbidity resulting in unsuitabil-
ity for home dialysis, while other causative relationships are
difficult to elucidate. In particular, rapid loss of renal function,
late referral, unplanned DI, acute infection and severe uraemia
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form a conglomerate of clinical problems collectively associated
with reduced choice of home dialysis modalities. A summary of
putative causal relationships is shown in Figure 3.
The use of assisted PD, defined as professional assistance in
the home, has been suggested to increase PD prevalence [32,
48]. However, we were unable to confirm this association.
There are several limitations of this study. As in all observational
studies, correlations do not prove causality. As compared with the
overall expected incidence of DI at the participating centres, an esti-
mated 19% of patients starting dialysis were not included in the
study. Non-included patients were not quantified or characterized
and may have differed from the included population. Social prob-
lems (e.g. poor dwelling conditions, social isolation, distance from
dialysis facility and illiteracy) were not quantified and would proba-
bly have increased the proportion of patients choosing in-centre
HD. Registration was incomplete for many variables, in particular
variables concerning the pre-dialysis course. This may have re-
duced the accuracy of the results. With these caveats in mind, it
should be noted as a strength of our study that we were able to pro-
spectively document detailed information on causes and timing of
DI and factors associated with the choice of initial dialysis modality
in a relatively large number of patients.
In summary, this study shows that given a personal choice,
most patients (65%) choose home dialysis. The results of the
study suggest that the incidence of home dialysis could poten-
tially be further increased if a number of organizational changes
are initiated, such as the establishment of a formal departmen-
tal ‘home dialysis first’ policy, steps to reduce late referral and
suboptimal DI, formalized post-DI education programmes for
late referrals with suboptimal DI and, for acutely ill patients, the
postponement (or repetition) of suitability assessment and mo-
dality choice until their condition has improved.
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